Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129655) titled 'Development of a Serological Monitoring Model for Liver Cancer Metastasis and an Interactive Application' on Aug. 7.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Jiangjin Central Hospital of Chongqing
Condition:
liver cancer
Intervention:
HCC Cohort(Metastatic Subgroup vs Non?Metastatic Subgroup):None
Normal:None
Other Solid Tumor Group (Lung Cancer):None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-21
Target Sample Size: HCC Cohort(Metastatic Subgroup vs Non?Metastatic Subgroup):200;Normal:100;Other Solid Tumor Group (Lung Cancer):...